Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr 17;12(4):e0175962.
doi: 10.1371/journal.pone.0175962. eCollection 2017.

Xp11.22 deletions encompassing CENPVL1, CENPVL2, MAGED1 and GSPT2 as a cause of syndromic X-linked intellectual disability

Affiliations

Xp11.22 deletions encompassing CENPVL1, CENPVL2, MAGED1 and GSPT2 as a cause of syndromic X-linked intellectual disability

Christina Grau et al. PLoS One. .

Abstract

By searching a clinical database of over 60,000 individuals referred for array-based CNV analyses and online resources, we identified four males from three families with intellectual disability, developmental delay, hypotonia, joint hypermobility and relative macrocephaly who carried small, overlapping deletions of Xp11.22. The maximum region of overlap between their deletions spanned ~430 kb and included two pseudogenes, CENPVL1 and CENPVL2, whose functions are not known, and two protein coding genes-the G1 to S phase transition 2 gene (GSPT2) and the MAGE family member D1 gene (MAGED1). Deletions of this ~430 kb region have not been previously implicated in human disease. Duplications of GSPT2 have been documented in individuals with intellectual disability, but the phenotypic consequences of a loss of GSPT2 function have not been elucidated in humans or mouse models. Changes in MAGED1 have not been associated with intellectual disability in humans, but loss of MAGED1 function is associated with neurocognitive and neurobehavioral phenotypes in mice. In all cases, the Xp11.22 deletion was inherited from an unaffected mother. Studies performed on DNA from one of these mothers did not show evidence of skewed X-inactivation. These results suggest that deletions of an ~430 kb region on chromosome Xp11.22 that encompass CENPVL1, CENPVL2, GSPT2 and MAGED1 cause a distinct X-linked syndrome characterized by intellectual disability, developmental delay, hypotonia, joint hypermobility and relative macrocephaly. Loss of GSPT2 and/or MAGED1 function may contribute to the intellectual disability and developmental delay seen in males with these deletions.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors of this manuscript have the following competing interests: DAS is a member of the Clinical Advisory Board of Baylor Genetics. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from genetic analyses offered through Baylor Genetics. Baylor Genetics did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of salaries for FX and SWC. These affiliations do not alter our adherence to PLOS ONE policies on sharing data and materials. The other authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Schematic representation of the Xp11.22 deletions carried by subjects 1–4.
The minimum (red) and maximum (yellow) deletions of each subject are shown in relation to the positon of Xp11.22 genes. The coordinates shown at the top of the figure are based on hg19. The maximum region of overlap is represented as dashed gray lines. The RefSeq genes located in this critical region—CENPVL1, CENPVL2, GSPT2 and MAGED1—are shown in red. Genes depicted in blue are deleted in a subset of subjects 1–4. Genes depicted in gray were not deleted in subjects 1–4.
Fig 2
Fig 2. Pedigree and array-based CNV analysis for subject 1.
(A) Subject 1 inherited an interstitial Xp11.22 deletion from his asymptomatic mother. His unaffected brother does not carry this deletion. Both subject 1 and his unaffected brother carry a maternally-inherited 17q12 deletion. (B) Data from the array-based CNV analyses performed on the subject 1 and his mother. The approximate locations of the RefSeq genes in this region are shown below. Genes depicted in red are those found in the maximal overlapping region encompassed by the deletions of subjects 1–4. Genes depicted in blue were deleted in a subset of subjects 1–4. Genes depicted in gray were not deleted in subjects 1–4.
Fig 3
Fig 3. Photos of subject 1 at various ages.
Subject 1 at (A) 4 days, (B) 6 days, (C) 1 month, (D-E) 1 year, (F) 2 years, and (G) 3 years of age. He does not have dysmorphic features. His congenital muscular torticollis resolved by 2 years of age. He had gross and fine motor delay attributable, at least in part, to his joint hypermobility. He could sit independently by 1 year of age (D) but required bracing to stand (E). At 22 months of age he could walk with the aid of a walker (F) and by 2 years 3 months of age he could walk independently.
Fig 4
Fig 4. Pedigree and array-based CNV analysis for subject 2.
(A) Subject 2 inherited an interstitial Xp11.22 deletion from his asymptomatic mother. (B) Data from the array-based CNV analyses performed on subject 2 and his mother. The approximate locations of the RefSeq genes in this region are shown below. Genes depicted in red are those found in the maximal overlapping region encompassed by the deletions of subjects 1–4. Genes depicted in blue were deleted in a subset of subjects 1–4.

Similar articles

Cited by

  • Characterization of large-scale genomic differences in the first complete human genome.
    Yang X, Wang X, Zou Y, Zhang S, Xia M, Fu L, Vollger MR, Chen NC, Taylor DJ, Harvey WT, Logsdon GA, Meng D, Shi J, McCoy RC, Schatz MC, Li W, Eichler EE, Lu Q, Mao Y. Yang X, et al. Genome Biol. 2023 Jul 4;24(1):157. doi: 10.1186/s13059-023-02995-w. Genome Biol. 2023. PMID: 37403156 Free PMC article.
  • Deletion of Maged1 in mice abolishes locomotor and reinforcing effects of cocaine.
    De Backer JF, Monlezun S, Detraux B, Gazan A, Vanopdenbosch L, Cheron J, Cannazza G, Valverde S, Cantacorps L, Nassar M, Venance L, Valverde O, Faure P, Zoli M, De Backer O, Gall D, Schiffmann SN, de Kerchove d'Exaerde A. De Backer JF, et al. EMBO Rep. 2018 Sep;19(9):e45089. doi: 10.15252/embr.201745089. Epub 2018 Jul 12. EMBO Rep. 2018. PMID: 30002119 Free PMC article.
  • Identification of a Locus on the X Chromosome Linked to Familial Membranous Nephropathy.
    Downie ML, Gupta S, Tekman MC, Cheshire C, Arora S, Licht C, Robinson LA, Munoz M, Aris AM, Al Attrach I, Brenchley PE, Gale DP, Stanescu H, Bockenhauer D, Kleta R. Downie ML, et al. Kidney Int Rep. 2021 Mar 3;6(6):1669-1676. doi: 10.1016/j.ekir.2021.02.025. eCollection 2021 Jun. Kidney Int Rep. 2021. PMID: 34169208 Free PMC article.
  • Identification of novel candidate disease genes from de novo exonic copy number variants.
    Gambin T, Yuan B, Bi W, Liu P, Rosenfeld JA, Coban-Akdemir Z, Pursley AN, Nagamani SCS, Marom R, Golla S, Dengle L, Petrie HG, Matalon R, Emrick L, Proud MB, Treadwell-Deering D, Chao HT, Koillinen H, Brown C, Urraca N, Mostafavi R, Bernes S, Roeder ER, Nugent KM, Bader PI, Bellus G, Cummings M, Northrup H, Ashfaq M, Westman R, Wildin R, Beck AE, Immken L, Elton L, Varghese S, Buchanan E, Faivre L, Lefebvre M, Schaaf CP, Walkiewicz M, Yang Y, Kang SL, Lalani SR, Bacino CA, Beaudet AL, Breman AM, Smith JL, Cheung SW, Lupski JR, Patel A, Shaw CA, Stankiewicz P. Gambin T, et al. Genome Med. 2017 Sep 21;9(1):83. doi: 10.1186/s13073-017-0472-7. Genome Med. 2017. PMID: 28934986 Free PMC article.
  • Genetic Analysis of the X Chromosome Associates Loci with Progression of Parkinson's Disease.
    Liao Y, Wu H, Wang J, Corvol JC, Maple-Grødem J, Campbell MC, Elbaz A, Brice A, Schwarzschild MA, Taba P, Kõks S, Beach TG, Alves G, Tysnes OB, Perlmutter JS, Maiti B, van Hilten JJ, Barker RA, Williams-Gray CH, Scherzer CR, Liu G; International Genetics of Parkinson Disease Progression Consortium. Liao Y, et al. Mov Disord. 2025 Jun 3:10.1002/mds.30252. doi: 10.1002/mds.30252. Online ahead of print. Mov Disord. 2025. PMID: 40459076

References

    1. Qiao Y, Liu X, Harvard C, Hildebrand MJ, Rajcan-Separovic E, Holden JJ, et al. (2008) Autism-associated familial microdeletion of Xp11.22. Clin Genet 74: 134–144. doi: 10.1111/j.1399-0004.2008.01028.x - DOI - PubMed
    1. Giorda R, Bonaglia MC, Beri S, Fichera M, Novara F, Magini P, et al. (2009) Complex segmental duplications mediate a recurrent dup(X)(p11.22-p11.23) associated with mental retardation, speech delay, and EEG anomalies in males and females. Am J Hum Genet 85: 394–400. doi: 10.1016/j.ajhg.2009.08.001 - DOI - PMC - PubMed
    1. Edens AC, Lyons MJ, Duron RM, Dupont BR, Holden KR (2011) Autism in two females with duplications involving Xp11.22-p11.23. Dev Med Child Neurol 53: 463–466. doi: 10.1111/j.1469-8749.2010.03909.x - DOI - PubMed
    1. Chung BH, Drmic I, Marshall CR, Grafodatskaya D, Carter M, Fernandez BA, et al. (2011) Phenotypic spectrum associated with duplication of Xp11.22-p11.23 includes Autism Spectrum Disorder. Eur J Med Genet 54: e516–520. doi: 10.1016/j.ejmg.2011.05.008 - DOI - PubMed
    1. Froyen G, Belet S, Martinez F, Santos-Reboucas CB, Declercq M, Verbeeck J, et al. (2012) Copy-number gains of HUWE1 due to replication- and recombination-based rearrangements. Am J Hum Genet 91: 252–264. doi: 10.1016/j.ajhg.2012.06.010 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources